Therefore, SLC7A1 may facilitate the malignant progression of meningioma through the regulation of E2F targets, G2M checkpoint, and MYC targets pathways via the SLC7A1-FOXM1/E2F4 axis. This evidence concerns the gene MYC and meningioma.